Management and Outcomes of Anti-CD38 Refractory Patients: The Impact of Retreatment and of Subsequent Therapies

Detalles Bibliográficos
Autores principales: Kastritis, Efstathios, Theodorakakou, Foteini, Stathopoulos, Ioannis-Ntanasis, Spiliopoulou, Vassiliki, Solia, Eirini, Malandrakis, Panagiotis, Syrigou, Rodanthi, Kokkali, Nikoleta, Migkou, Magdalini, Eleutherakis-Papaiakovou, Evangelos, Fotiou, Despina, Roussou, Maria, Kanellias, Nikolaos, Gavriatopoulou, Maria, Terpos, Evangelos, Dimopoulos, Meletios A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10627622/
https://www.ncbi.nlm.nih.gov/pubmed/37936678
http://dx.doi.org/10.1097/HS9.0000000000000975

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10627622/
https://www.ncbi.nlm.nih.gov/pubmed/37936678
http://dx.doi.org/10.1097/HS9.0000000000000975

Ejemplares similares